Loading data for HCWB — first visit, this takes a few seconds.
HCW Biologics Inc. (HCWB)
NasdaqCM: HCWB
· Real-Time Price · USD
3.17
+0.47 (17.41%)
At close: Aug 27, 2026, 3:59 PM
3.03
-4.42%
After-hours: 7:37 PM
The price, the headline numbers and the latest news, in one place.
HCW Biologics Inc. (HCWB) Stock Price, Analysis & Data
17.41% (1D)
| Bid | 2.32 |
| Market Cap | 5.82M |
| Revenue (ttm) | 6.72M |
| Net Income (ttm) | -21.41M |
| 2.36 | |
| -16.62 | |
| n/a | |
| -5.76 | |
| P/B (ttm) | 0.69 |
| P/S (ttm) | 0.87 |
| Earnings Date | n/a |
| Ask | 3.75 |
| Volume | 313,684 |
| Avg. Volume (20D) | 151,895 |
| Open | 2.70 |
| Previous Close | 2.70 |
| Day's Range | 2.60 - 3.28 |
| 52-Week Range | 1.50 - 38.16 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About HCWB
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which ...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 20, 2021
Employees 35
Stock Exchange NasdaqCM
Ticker Symbol HCWB
Website https://www.hcwbiologics.com
Financial Performance
In 2025, HCW Biologics's revenue was 54.23K, a decrease of -97.89% compared to the previous year's 2.57M. Earnings were -7.96M, a decrease of -73.49%.
Financial StatementsEarnings Surprise
HCW Biologics has released their quarterly earnings on Aug 14, 2026:
- Revenue of $6.54M misses estimates by $0, with 129080.67% YoY growth.
- EPS of -11.58 misses estimates by -9.60, with 71.58% YoY growth.
5 months ago · Associated Press Finance
BC-Most Active StocksYY Group Holdings Ltd. 26,117,734 0.0511